End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.49 CNY | +1.03% | +12.17% | +23.07% |
Apr. 19 | Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 18 | Haisco Pharmaceutical Gets Nod to Trial HSK16149 Capsules | MT |
Sales 2024 * | 3.88B 535M | Sales 2025 * | 5.1B 704M | Capitalization | 31.44B 4.34B |
---|---|---|---|---|---|
Net income 2024 * | 552M 76.18M | Net income 2025 * | 633M 87.36M | EV / Sales 2024 * | 8.11 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.16 x |
P/E ratio 2024 * |
57
x | P/E ratio 2025 * |
50.4
x | Employees | 5,448 |
Yield 2024 * |
0.42% | Yield 2025 * |
0.53% | Free-Float | 20.41% |
1 day | +1.03% | ||
1 week | +12.17% | ||
Current month | +5.01% | ||
1 month | +8.20% | ||
3 months | +24.63% | ||
6 months | +23.44% | ||
Current year | +23.07% |
Managers | Title | Age | Since |
---|---|---|---|
Xiu Lian Fan
CEO | Chief Executive Officer | 61 | 06-12-31 |
Peng Duan
DFI | Director of Finance/CFO | 49 | 16-10-20 |
Jun Min Wang
CHM | Chairman | 56 | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jun Min Wang
CHM | Chairman | 56 | 06-12-31 |
Wei Zheng
BRD | Director/Board Member | 54 | 06-12-31 |
Xiu Lian Fan
CEO | Chief Executive Officer | 61 | 06-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 28.49 | +1.03% | 5 014 870 |
24-04-25 | 28.2 | +3.37% | 5,018,471 |
24-04-24 | 27.28 | +1.41% | 3,321,500 |
24-04-23 | 26.9 | +1.89% | 4,695,500 |
24-04-22 | 26.4 | +1.89% | 5,111,822 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.07% | 4.3B | |
+26.13% | 653B | |
+27.00% | 556B | |
-6.56% | 354B | |
+20.53% | 331B | |
+3.13% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.20% | 144B |
- Stock Market
- Equities
- 002653 Stock